Efficacy and safety study of defibrotide (DF) for the treatment of venoocclusive disease (VOD).
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2017
Price : $35 *
At a glance
- Drugs Defibrotide (Primary)
- Indications Veno-occlusive disorders
- Focus Therapeutic Use
- 06 Feb 2017 Status changed from active, no longer recruiting to completed.
- 12 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 26 May 2014 New trial record